EPISODE · Feb 9, 2024 · 1H 3M
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
from The Long Run with Luke Timmerman · host Timmerman Report
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
What this episode covers
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
NOW PLAYING
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m